INTRODUCTION
Interaction between T lymphocytes and professional APCs is critical for the development of adaptive immunity. Increasing evidence has shown that the interaction between CD40 and its counter-receptor CD154 is pivotal for the induction of both humoral and cell-mediated immune responses. 1 In the presence of appropriate cytokines, ligation of CD40 on B cells induces clonal expansion and differentiation to Igsecreting cells (reviewed by Foy et al. 2 and van Kooten and Banchereau 3 ). Similarly, engagement of CD40 on macrophages and dendritic cells stimulates cytokine and chemokine production, enhances their antigen-presentation capability by up-regulating co-stimulatory molecules, induces macrophage effector functions, and protects APCs against apoptosis. 4 CD40-CD154 interaction is pivotal for the development of Th1-type immune response as it governs the ability of T cells to induce IL-12 secretion by macrophages and dendritic cells. Our understanding of the role of CD40-CD154 interactions in adaptive immunity remains incomplete because while they appear to be critical for resistance to some intracellular parasites such as Leishmania, [5] [6] [7] CD40-CD154 seem not to be required for others such as Mycobacterium tuberculosis and Histoplasma capsulatum. 8, 9 In this report, we addressed the requirement for the CD40-CD154 pathway in initiating and regulating the immune response to Salmonella infection. Salmonellae are Gram-negative, enteric, pathogens responsible for disease syndromes of significant morbidity and mortality worldwide. Being facultative intracellular pathogens, immunity to Salmonella infections requires adequate humoral and cell-mediated immune responses. 10, 11 Since CD40-CD154 interactions play a pivotal role in the regulation of both arms of the immune system, the murine Salmonella model represents a particularly attractive system in which to study their contribution.
MATERIALS AND METHODS

Mice
CD154 -/mice in the C57BL/6 background (backcrossed for > 20 generations) were derived from a colony generated and described previously. 12 They were bred in our animal facility and maintained in filter-topped isolator cages on Bactrim-supplemented water. Control C57BL/6 mice, designated CD154 +/+ mice, were obtained from Harlan Olac (Bicester, UK). All animals were used at 8-12 weeks of age in accordance with, and after approval of, the Animal Research Ethics Committee of the Faculty of Medicine and Health Sciences, UAE University.
Bacterial strains and growth conditions
The characteristics of the bacterial strains have been described. 13, 14 BRD509 is an attenuated aroA -/aroDmutant strain of S. enterica serovar Typhimurium 15 and SL1344 is a virulent Salmonella strain from which BRD509 was originally derived. 15, 16 In C57BL/6 mice, the LD 50 of BRD509 and SL1344 strains, given i.p., are > 5 x 10 6 and < 10 CFU, respectively. Log-phase bacterial suspensions were prepared in pyrogen-free saline and injected i.p. in 0.5 ml volume. For all experiments, bacterial doses were confirmed by CFU plate counts.
Enumeration of bacteria in liver and spleen homogenates
Detailed procedures for determination of CFUs have been published previously. 13, 17 Aliquots of the homogenates were plated on T-soy agar plates and viable CFUs were determined after an overnight incubation. Duplicate plates were set up for each dilution or experimental group. Results are expressed as CFUs/spleen.
Cell preparation and cytokine analysis
Erythrocyte-depleted spleen single cell suspensions were prepared as previously described. 14, 17 Cells were cultured at a concentration of 5 x 10 6 cells/ml in 24-well plates with or without 50 µl of Salmonella sonicate (standardized by protein content) or ConA as a positive control. Cells were incubated for 48 h at 37°C with 5% CO 2 . Culture supernatants were collected 48 h later, and assayed for IFN-γ content using a Duoset ELISA development system from R&D Systems (Minneapolis, MN, USA), according to the manufacturer's instructions. The limit of detection is ~30 pg/ml.
RNA preparation and RT-PCR
The detailed procedure has been described elsewhere. 18 Extracted RNA from spleen cells was reverse transcribed using AMV reverse transcriptase (Promega, Madison, WI, USA). Primer sequences for iNOS and βactin were reported previously. 17 PCR was performed under the following cycling conditions: 94°C for 1 min, 60°C for 2 min, and 72°C for 3 min for 30 cycles. Reaction products were visualized by electrophoresis on a 2% agarose gel and ethidium bromide staining.
Statistical analysis
Statistical significance was analyzed using Student's ttest. Differences between experimental groups were considered significant when P values were < 0.05.
RESULTS
CD40-CD154 interactions are required for resolution of infection with attenuated S. typhimurium
It was previously reported that administration of a CD40 agonist to normal BALB/c mice augmented resistance to infection with a virulent strain of Salmonella dublin. 19 Surprisingly, however, the same study also showed that CD154 -/mice failed to exhibit any increased susceptibility to infection. We decided to revisit this issue by analyzing the in vivo response of CD154 -/mice to an attenuated aroA -/aroDstrain of S. typhimurium (designated strain BRD509). As shown in Figure 1A , CD154 -/mice failed to recover and succumbed to infection within a period of about 16 days. In contrast, CD154 +/+ mice were able to control bacterial growth effectively with no deaths observed in this group. The heightened susceptibility of CD154 -/mice was associated with a failure to control bacterial growth (Fig. 1B) . These data demonstrate that CD40-CD154 interactions are critical for resistance to infection with attenuated S. typhimurium.
Impaired Th1 response in CD154 -/mice
Resistance to Salmonella infections is thought to occur via Th1-mediated activation of host target cells, leading to bacterial clearance (reviewed by Raupach and Kaufmann 20 ) . Previous studies have demonstrated the requirement for CD40-CD154 interactions in pathways leading to the production of IL-12, IFN-γ and NO. [21] [22] [23] [24] To assess the generation of Salmonella-specific Th1 response, mice were inoculated with a sublethal dose of BRD509 strain and, 8 weeks later, spleen cells were tested for their ability to produce IFN-γ in response to a recall Salmonella challenge in vitro. Spleen cells of immunized mice cultured in medium alone failed to secrete any detectable IFN-γ (data not shown). When a preparation of sonicated Salmonella antigens was added, spleen cells of BRD509-immunized CD154 +/+ mice responded with the release of significant quantities of IFN-γ in a dose-dependent fashion ( Fig. 2A) . In contrast, spleen cells of similarly-treated CD154 -/mice produced 5.5-10.8-fold lower levels of IFN-γ than CD154 +/+ cells (P < 0.05 at all three concentrations of antigen used). In both mouse strains, spleen cells from saline-treated mice failed to produce any detectable IFN-γ in response to Salmonella antigens (data not shown). Splenocyte cultures, of either mouse strain, stimulated with the pan Tcell mitogen ConA produced significantly elevated levels of IFN-γ (24.7 ± 2.7 and 19.8 ± 0.5 ng/ml for CD154 +/+ and CD154 -/mice, respectively).
Nitric oxide production
One of the critical functions of IFN-γ in anti-Salmonella immunity is the activation of antimicrobial potential of macrophages by enhancing, among other mechanisms, the release of nitric oxide (NO). Therefore, the ability of infected splenocytes of CD154 +/+ and CD154 -/mice to produce NO was assessed by analysis of iNOS gene expression by RT-PCR. As can be seen in Figure 2B , CD154 +/+ mice infected with strain BRD509 exhibited stronger and more sustained expression of iNOS than CD154 -/mice. These data demonstrate that, in response to Salmonella infection, CD154 -/mice have a functional impairment in their ability to secrete IFN-γ, a key proinflammatory mediator, as well as NO, a critical antimicrobial macrophage factor.
DISCUSSION
The findings of this study demonstrate that expression of CD154 protein is critical for defense against a primary infection with attenuated Salmonella. The heightened susceptibility of CD154 -/mice to Salmonella infection is associated with an increased bacterial burden in target CD154 is required for resistance to Salmonella infections 397 The level of bacterial load in the spleen was assessed at the indicated days post inoculation with a dose of 0.6 x 10 6 BRD509 organisms per mouse. Asterisks denote significant differences between corresponding CD154 +/+ and CD154 -/mouse strains at each time point (**P < 0.01). Each datum point represents the mean ± SEM of 3 mice per group. Control (saline injected) mice were also included in each experiment and showed no bacterial CFUs (data not shown).
organs and correlates with a defective generation of a protective Th1-type immune response. Moreover, post mortem analysis of CD154 -/mice infected with a high dose (> 1 x 10 6 cells/mouse) of the BRD509 mutant has consistently shown high CFUs (10 7 -10 8 CFUs/organ) in the spleen (data not shown). Our findings differ somewhat from a previous study which reported that CD154 -/mice exhibit no increase in susceptibility to Salmonella infection. 19 In that study, a virulent strain of S. dublin was used which, we surmise, might well have precluded any demonstration of increased susceptibility by the CD154 -/mice. In the present study, the demonstrated susceptibility of CD154 -/mice to an attenuated aroA -/aroDstrain of S. typhimurium is similar to that previously reported for athymic mice, 25 mice deficient in CD4 + T cells 26 or CD28 co-stimulatory molecule. 27, 28 Thus, CD40/CD154-dependent crosstalk between APCs and T cells is critical for resistance to infection by attenuated Salmonella organisms.
In our study, the majority of animals deficient in CD154 began to show signs of morbidity by day 9 and succumbed to infection 11-16 days post inoculation. This pattern of susceptibility in response to a primary infection suggests a defective development of innate immune mechanisms in these animals. During the innate phase of the immune response, phagocytic cells (primarily, macrophages and neutrophils) function to limit the intracellular replication of the bacteria as well as their spread to surrounding tissue in the liver parenchyma. 29, 30 The efficiency of this containment depends to a great extent on the production of TNF-α and IFN-γ, which are secreted primarily by macrophages and NK cells, and augmented by IL-12, a product of macrophages and dendritic cells. 31 Our findings demonstrate that CD154 -/mice are unable to produce normal levels of IFN-γ in response to infection, thereby decreasing the effectiveness of their innate immune mechanisms which leads to a failure in the control of early bacterial replication.
CONCLUSIONS
Using the murine systemic Salmonella model, evidence is provided in support of an essential role for CD154 in resistance to infection with attenuated Salmonella during the innate phase of disease. The data suggest that CD154 may mediate its effects through influencing the release of pro-inflammatory cytokines by APCs which are required for control of the infection. Fig. 2 . Decreased secretion of inflammatory mediators by Salmonellainfected CD154 -/mice. (A) Mice were immunized (2 x 10 5 BRD509 organisms per mouse) and, 16 weeks later, spleen cells were tested for their ability to respond to Salmonella antigens. Cells were cultured at 5 x 10 6 cells/ml in the absence or presence of a sonicated Salmonella preparation at the indicated concentrations. After 48-h of culture, cell-free culture supernatants were collected and assayed for IFN-γ by a specific ELISA. Each datum point represents the mean ± SE of 3 mice per group. Asterisks denote significant differences between corresponding CD154 +/+ and CD154 -/mouse strains at each time point (**P < 0.01; ***P < 0.001). The results are representative of three independent experiments. (B) RT-PCR analysis of iNOS gene expression by saline or BRD509-injected mice. Extracted RNA was reverse transcribed and amplified using primers specific for the murine IFN-γ gene. As a control, PCR reaction was also carried out using primers specific to β-actin. Each lane is a representative result of 1 of 3 mice per group for each time point post treatment. Data are representative of three independent experiments.
